Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

On Tuesday, Inari Medical Inc (NARI) stock saw a decline, ending the day at $79.5 which represents a decrease of $-0.05 or -0.06% from the prior close of $79.55. The stock opened at $79.54 and touched ...

Quanterix Corporation (NASDAQ: QTRX)'s merger with Akoya Biosciences, Inc. Upon completion of the proposed transaction, Quanterix shareholders will own approximately 70% of the combined company. If ...

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at where Inari Medical, Inc. (NASDAQ:NARI) stands against the other smid-cap ...

January 21, 2025) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Inari Medical, Inc. ("Inari Medical") (NASDAQ: NARI) for ...

UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00.

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

We recently compiled a list of the 10 Hottest Mid-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Stryker (SYK) announced that it commenced, through a wholly owned subsidiary, Eagle 1 Merger Sub Inc., a cash tender offer to ...